All articles tagged with #blood oxygen sensor
Apple is appealing a trade ban that forced it to remove the blood oxygen sensor from its Apple Watch due to patent disputes with Masimo, with ongoing legal battles over the sensor's legality and potential reintroduction in future models.
Apple CEO Tim Cook reassures customers that there are still plenty of reasons to buy the Apple Watch Series 9 despite the disabled blood oxygen sensor, citing its other features. However, the ongoing patent dispute with Masimo means there's no end in sight for the ban, potentially affecting the watch's appeal. While Apple is focused on appeal, third-party retailers like Amazon and Best Buy can still sell existing stock with the feature.
Masimo CEO Joe Kiani confirmed that there have been no discussions with Apple about a possible settlement regarding the legal dispute over the Apple Watch blood oxygen sensor, which allegedly uses Masimo-patented technology. Kiani criticized the sensor's reliability and lack of FDA clearance, stating that consumers are "better off without it." The U.S. International Trade Commission ruled in favor of Masimo, leading to an import ban on Apple Watch models with a functional blood oxygen sensor in the U.S. As a result, Apple is selling modified models without the sensor enabled, but may update them in the future pending a settlement or ruling overturn.
The U.S. Court of Appeals has upheld a ban preventing Apple from selling watches with blood oxygen sensors due to an ongoing intellectual property dispute with medical device company Masimo. The ban affects the Apple Watch Series 9 and Ultra 2, but Apple may have received approval for a modified version without the blood oxygen feature. Masimo is open to settling with Apple, and the ban could complicate repairs at Apple stores.
Apple has reportedly started shipping new Watch Series 9 and Ultra 2 models without the blood oxygen sensor functionality that led to a patent dispute, indicating a software change rather than a hardware one. The company is likely preparing for a potential import ban by US Customs and Border Protection, with a court decision on the appeal expected soon. Current users of the affected watches may not be impacted immediately, but it's advisable to stay informed about any upcoming Apple updates that could potentially affect the functionality of the blood oxygen sensor.
Apple is removing the blood-oxygen sensor from some of its smartwatches to circumvent a patent dispute with medical device maker Masimo, which led to a U.S. import ban on most of the tech company's watch models. This move, aimed at avoiding further sales disruptions, raises questions about Apple's focus on health technology.
Apple has announced that it will halt sales of its latest smartwatches, including the Apple Watch Series 9 and Apple Watch Ultra 2, due to a patent dispute over the devices' blood-oxygen sensor. The move comes after a federal trade agency found that Apple violated the patent of medical technology company Masimo. Apple has decided to preemptively stop sales while pursuing legal and technical options to ensure availability to customers. Sales of the smartwatches will continue outside of the U.S. Apple has also accused Masimo of stealing patented features from Apple for its own smartwatch.